1-[3-[4-(2-cyclopentyloxy-5-fluorophenyl)piperazin-1-yl]propyl]-3-[(cyclopropylamino)methyl]pyrrole-2,5-diol
C26H37FN4O3 — CID 90729601
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[3-[4-(2-cyclopentyloxy-5-fluorophenyl)piperazin-1-yl]propyl]-3-[(cyclopropylamino)methyl]pyrrole-2,5-diol
1-[3-[4-(2-cyclopentyloxy-5-fluorophenyl)piperazin-1-yl]propyl]-3-[(cyclopropylamino)methyl]pyrrole-2,5-diol (PubChem CID 90729601) has the molecular formula C26H37FN4O3 and a molecular weight of 472.61 g/mol. Its IUPAC name is 1-[3-[4-(2-cyclopentyloxy-5-fluorophenyl)piperazin-1-yl]propyl]-3-[(cyclopropylamino)methyl]pyrrole-2,5-diol.
Molecular Properties
| Compound Name | 1-[3-[4-(2-cyclopentyloxy-5-fluorophenyl)piperazin-1-yl]propyl]-3-[(cyclopropylamino)methyl]pyrrole-2,5-diol |
|---|---|
| PubChem CID | 90729601 |
| Molecular Formula | C26H37FN4O3 |
| Molecular Weight | 472.61 g/mol |
| Exact Mass | 472.28 |
| IUPAC Name | 1-[3-[4-(2-cyclopentyloxy-5-fluorophenyl)piperazin-1-yl]propyl]-3-[(cyclopropylamino)methyl]pyrrole-2,5-diol |
| SMILES | Oc1cc(CNC2CC2)c(O)n1CCCN1CCN(c2cc(F)ccc2OC2CCCC2)CC1 |
| InChI | InChI=1S/C26H37FN4O3/c27-20-6-9-24(34-22-4-1-2-5-22)23(17-20)30-14-12-29(13-15-30)10-3-11-31-25(32)16-19(26(31)33)18-28-21-7-8-21/h6,9,16-17,21-22,28,32-33H,1-5,7-8,10-15,18H2 |
| InChIKey | CJTCZWONCAKOKJ-UHFFFAOYSA-N |
| XLogP | 3.82 |
| TPSA | 73.13 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 472.61 |
| LogP ≤ 5 | 3.82 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 90729601 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.